Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
JTO Clinical and Research Reports
|
March 7, 2022
An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study
Po-Lan Su, Gee-Chen Chang, Shih-Hsin Hsiao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 18, 2021
EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
Jeng-Shiuan Tsai, Po-Lan Su, Szu-Chun Yang, et al.
World Journal of Surgical Oncology
|
November 25, 2023
Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients
Pang-Shuo Perng, Heng-Juei Hsu, Jung-Shun Lee, et al.
Thoracic Cancer
|
November 20, 2021
Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors
Sheng-Yuan Wang, Ching-Han Lai, Chian-Wei Chen, et al.
Cancer Medicine
|
August 22, 2019
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment
Po-Lan Su, Szu-Chun Yang, Yi-Lin Chen, et al.
Scientific Reports
|
March 30, 2021
Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy
Hsien-Yuan Chang, Chun-Hui Lee, Po-Lan Su, et al.
Biosensors & Bioelectronics
|
September 10, 2023
Single-sized N-functionality graphene quantum dot in tunable dual-modality near infrared-I/II illumination detection and photodynamic therapy under multiphoton nonlinear excitation
Wen-Shuo Kuo, Chia-Yuan Chang, Hao-Yu Chuang, et al.
Thoracic Cancer
|
May 15, 2023
Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study
Chien-Yu Lin, Chia-Hao Hu, Chia-Fu Hsu, et al.
Biosensors & Bioelectronics
|
December 4, 2023
Corrigendum to "Single-sized N-functionality graphene quantum dot in tunable dual-modality near infrared-I/II illumination detection and photodynamic therapy under multiphoton nonlinear excitation" [Biosens. Bioelectron. 241 (2023) 115648/ DOI: 10.1016/j.bios.2023.115648]
Wen-Shuo Kuo, Chia-Yuan Chang, Hao-Yu Chuang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 2, 2021
Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment
Po-Lan Su, Jeng-Shiuan Tsai, Szu-Chun Yang, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
JTO Clinical and Research Reports
|
March 7, 2022
An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study
Po-Lan Su, Gee-Chen Chang, Shih-Hsin Hsiao, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 18, 2021
EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
Jeng-Shiuan Tsai, Po-Lan Su, Szu-Chun Yang, et al.
World Journal of Surgical Oncology
|
November 25, 2023
Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients
Pang-Shuo Perng, Heng-Juei Hsu, Jung-Shun Lee, et al.
Thoracic Cancer
|
November 20, 2021
Improved survival in patients with unresectable stage III EGFR-mutant adenocarcinoma with upfront EGFR-tyrosine kinase inhibitors
Sheng-Yuan Wang, Ching-Han Lai, Chian-Wei Chen, et al.
Cancer Medicine
|
August 22, 2019
Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment
Po-Lan Su, Szu-Chun Yang, Yi-Lin Chen, et al.
Scientific Reports
|
March 30, 2021
Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy
Hsien-Yuan Chang, Chun-Hui Lee, Po-Lan Su, et al.
Biosensors & Bioelectronics
|
September 10, 2023
Single-sized N-functionality graphene quantum dot in tunable dual-modality near infrared-I/II illumination detection and photodynamic therapy under multiphoton nonlinear excitation
Wen-Shuo Kuo, Chia-Yuan Chang, Hao-Yu Chuang, et al.
Thoracic Cancer
|
May 15, 2023
Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study
Chien-Yu Lin, Chia-Hao Hu, Chia-Fu Hsu, et al.
Biosensors & Bioelectronics
|
December 4, 2023
Corrigendum to "Single-sized N-functionality graphene quantum dot in tunable dual-modality near infrared-I/II illumination detection and photodynamic therapy under multiphoton nonlinear excitation" [Biosens. Bioelectron. 241 (2023) 115648/ DOI: 10.1016/j.bios.2023.115648]
Wen-Shuo Kuo, Chia-Yuan Chang, Hao-Yu Chuang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 2, 2021
Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment
Po-Lan Su, Jeng-Shiuan Tsai, Szu-Chun Yang, et al.
Page
of 7